OMAHA - Clinical research sponsored by the pharmaceutical industry produced an estimated economic impact in the state of $394 million in 2017, according to a new report by the Pharmaceutical Research and Manufacturers of America, known as PhRMA.

Since 2004, nearly 3,000 clinical trials have been conducted in Nebraska, said Zachary Poss, senior manager for state advocacy with the industry group. Today, there are 326 industry-sponsored trials open at hospitals, clinics and other sites across the state serving more than 8,000 Nebraskans. They focus on drug treatments for conditions including cancer, arthritis and infectious diseases.

View the article HERE